Molecular Targeting Technologies Competitors and Similar CompaniesClear all
Molecular Targeting Technologies's competitors and similar companies include Cardiff Oncology and BioInvent.
 Molecular Targeting Technologies Molecular Targeting Technologies is a biotech company developing diagnostic and therapeutic molecules for cancer and cardiovascular diseases. | |||
Founding Date | Founding Date N/A | Founding Date 1999 | Founding Date 1997 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations West Chester, US HQ | Locations San Diego, US HQ | Locations Lund, SE HQ |
Employees | Employees 717% increase | Employees 14 | Employees 118 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 145.2 m | Valuation ($) 285.9 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $593k (FY, 2025) | Revenue (est.) kr226.5m (FY, 2025) |
Net income | Net income N/A | Net income ($45.9m) (FY, 2025) | Net income (kr332.9m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
BioInvent
HQ
Lund, SE
Employees
118
BioInvent focuses on the discovery and development of antibody-based drugs against cancer.
View company